Tirzepatide 5 mg
  1. Home
  2. Mounjaro
  3. Tirzepatide 5 mg

Tirzepatide 5 mg

Tirzepatide 5 mg is a prescription dual GIP and GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is administered as a once-weekly subcutaneous injection using a prefilled injection pen. The 5 mg strength is commonly prescribed after the initial treatment phase according to the recommended dose-escalation schedule.

BUY NOW

Category

Tirzepatide 5 mg contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 5 mg dose is typically prescribed following the initial 2.5 mg treatment phase to provide enhanced glycemic control while supporting gradual dose escalation. Manufactured under stringent pharmaceutical quality standards, the sterile prefilled injection pen is engineered for precise subcutaneous administration and dependable clinical performance. Tirzepatide 5 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Tirzepatide 5 mg
Active Ingredient Tirzepatide
Strength 5 mg
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Tirzepatide 5 mg, Tirzepatide Injection 5 mg, Tirzepatide Prefilled Pen, Weekly Tirzepatide Injection, GIP GLP-1 Receptor Agonist, Diabetes Injection Pen, Tirzepatide Injection Pen